Mitsubishi Tanabe, Jichi Medical Univ. to Commence AMED-Funded Hemophilia Gene Therapy Research

August 7, 2019
Mitsubishi Tanabe Pharma and Jichi Medical University said on August 6 that they are set to initiate an R&D project for a gene therapy product for hemophilia B in Japan, which was selected in October last year by the Japan...read more